Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing
Authors:
- 19 March 2018
- journal article
- editorial
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 39 (5) , 625-627
Abstract
C. difficile PCR testing identifies both colonized and infected patients, making it critical to only test patients that meet clinical criteria for C. difficile infection (CDI). We implemented an automated order-entry protocol that reduced inappropriate testing by 64% and hospital-onset (HO) CDI Standardized Infection Ratio (SIR) from 1.62 to 0.82.Keywords
This publication has 10 references indexed in Scilit:
- Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012–2014: prospective, repeated cross-sectional studyClinical Microbiology and Infection, 2017
- Short- and long-term effects of oral vancomycin on the human intestinal microbiotaJournal of Antimicrobial Chemotherapy, 2016
- Overdiagnosis ofClostridium difficileInfection in the Molecular Test EraJAMA Internal Medicine, 2015
- Burden ofClostridium difficileInfection in the United StatesNew England Journal of Medicine, 2015
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivityJournal of Hepatology, 2014
- Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical LaboratoriesClinical Microbiology Reviews, 2013
- Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile InfectionsAmerican Journal of Gastroenterology, 2013
- Electronic Health Records and National Patient-Safety GoalsNew England Journal of Medicine, 2012
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)Infection Control & Hospital Epidemiology, 2010
- Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile -Associated DiseaseAntimicrobial Agents and Chemotherapy, 2008